Application of Lean Six Sigma Combined with Pre-Prescription Review System in Reducing the Irrational Rate of Emergency Prescriptions: A Single Center Study

应用精益六西格玛结合处方前审核系统降低急诊处方不合理率:一项单中心研究

阅读:1

Abstract

PURPOSE: To explore the application of Lean Six Sigma (LSS) combined with pre-prescription review system in reducing the irrational rate of emergency prescriptions. METHODS: The emergency prescriptions of our hospital in May 2022 to May 2023 and June 2023 to December 2024 were selected as the research objects. Based on the pre-prescription review system and LSS, a comparative analysis was carried out regarding the irrational rate of emergency prescriptions, the changing trend of the irrational rate, the types of irrational prescriptions and their departmental distribution, patients' satisfaction, and the proportion of doctors' returning and modifying irrational prescriptions before and after the implementation of intervention measures. RESULTS: After the adoption of LSS and Review system, the irrational rate of emergency prescriptions was significantly reduced (P<0.001); The irrational prescription rate decreased by 0.07% (P<0.001, 95% CI=[-0.06, 0.20]) month by month; The main types of irrational prescriptions remained unchanged, but except for combination medication, incompatibility and repeated medication, all types of irrational prescriptions were significantly lower than those before the intervention (P<0.05); Before and after the intervention, the irrational prescriptions were mainly issued by emergency internal medicine and urology emergency department, and the pediatric emergency department increased after the intervention; Patients' satisfaction was significantly improved after intervention (P<0.05); The proportion of physicians returning to correct irrational prescriptions increased significantly after the intervention (P<0.001). CONCLUSION: LSS combined with pre-prescription review system can effectively reduce the irrational rate of emergency prescriptions, optimize emergency medication management, and ensure patient medication safety.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。